North Korea vs Maldives: Immunization, Hib3
North Korea
99.0%
in 2024
Maldives
99.0%
in 2024
North Korea rank
1st
Maldives rank
1st
Immunization, Hib3 over time
- North Korea
- Maldives
How they compare
North Korea currently reports 99.0% against 99.0% in Maldives, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2013 it was North Korea ahead.
North Korea ranks 1st and Maldives ranks 1st of 191 countries.
North Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Korea | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.6% | 92.6% | 3.0% | North Korea |
| 2020s | 98.6% | 97.6% | 1.0% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, North Korea or Maldives?
- North Korea, at 99.0% against 99.0% in Maldives as of 2024.
- What is the difference in immunization, hib3 between North Korea and Maldives?
- 0.0%, with North Korea ahead.
- How many years of comparable data are there for North Korea and Maldives?
- 12 years are reported by both, from 2013 to 2024.
- How do North Korea and Maldives rank globally for immunization, hib3?
- North Korea ranks 1st and Maldives ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.